Skip to main content
. 2025 Jun 10;312(3):857–870. doi: 10.1007/s00404-025-08059-7

Table 1.

General characteristics of PCOS and control groups

Parameter PCOS (n = 161) Control (n = 107) P-value
Age (years) 24.79 ± 4.86 24.29 ± 4.83 0.410
BMI (kg/m2) 22.87 ± 4.06 19.91 ± 1.76  < 0.001
AMH (ng/mL) 7.85 ± 3.24 3.63 ± 1.96  < 0.001
HCY (μmol/L) 11.73 ± 3.71 6.90 ± 2.09  < 0.001
HOMA-IR 2.23 ± 1.89 1.53 ± 0.72  < 0.001
Fasting Insulin (μIU/mL) 9.91 ± 7.52 7.51 ± 3.36  < 0.001
Fasting Blood Glucose (mmol/L) 4.91 ± 0.48 4.58 ± 0.35  < 0.001
CRP (mg/L) 2.24 ± 2.73 1.35 ± 1.39 0.001
Triglycerides (mmol/L) 1.20 ± 0.75 0.87 ± 0.46  < 0.001
HDL (mmol/L) 1.47 ± 0.37 1.73 ± 0.35  < 0.001
LDL (mmol/L) 2.66 ± 0.73 2.40 ± 0.70 0.004
Total Cholesterol (mmol/L) 4.75 ± 0.86 4.47 ± 0.82 0.008
TXNIP (ng/mL) 0.32 ± 0.09 0.29 ± 0.05  < 0.001

Note: P < 0.05 indicates statistical significance. Data are expressed as mean ± standard deviation

Abbreviation: BMI body mass index, AMH anti-Müllerian hormone, HCY homocysteine, HOMA-IR homeostatic model assessment of insulin resistance, FIns fasting insulin, FBG, fasting blood glucose, CRP C-reactive protein, TG triglycerides, HDL high-density lipoprotein, LDL low-density lipoprotein, TC total cholesterol, TXNIP thioredoxin-interacting protein